No Data
Global Trade to Decline in 2025 Amid Increased Tariff Uncertainty, WTO Says
Charle To Go Ex-Dividend On March 28th, 2025 With 8 JPY Dividend Per Share
March 27th (Japan Standard Time) - $Charle(9885.JP)$ is trading ex-dividend on March 28th, 2025.Shareholders of record on March 31st, 2025 will receive 8 JPY dividend per share. The ex-dividend date
February 27 [Today's Investment Strategy]
[FISCO Selected Stocks] 【Material Stocks】 Allied Telesis Holdings <6835> 259 yen (2/26) provides IT solutions. It announced a Share Buyback of 2 million shares, amounting to up to 0.5 billion yen, which corresponds to 1.86% of the issued shares. The acquisition period is from February 27 to May 31, 2025. This action is part of a flexible capital policy and shareholder returns in response to changes in the business environment. As of January 31, 2025, the shareholding of treasury shares is 2.01 million 5802.
Pay attention to research drugs and Gunma Silver, while Tochigi Silver and others may be soft.
In the US stock market on the 26th, the Dow Jones Industrial Average fell by 188.04 points to 43,433.12, the Nasdaq Composite Index rose by 48.87 points to 19,075.26, and the Chicago Nikkei 225 Futures decreased by 165 yen compared to Osaka during the day to 38,055 yen. The exchange rate was 1 dollar = 149.10-20 yen. In today's Tokyo market, Gunma Bank (8334) announced a change in its shareholder return policy, an upward revision of its Dividends forecast, and a 2.40% share buyback of issued Stocks.
＜Today's Individual Materials＞ EED, Kyoken Pharmaceuticals, Asahi Organic Materials, WACUL ETC (Announcement on the 26th)
▽ EID <6038.T>, revised the ordinary Dividends to 16 yen at the end of the fiscal year in June 2025, adding a commemorative Dividends of 6 yen for the 25th anniversary, making a total of 22 yen (the previous period had an ordinary Dividends of 14 yen). At the same time, a commemorative Shareholder benefit will be implemented, presenting a Quo Card worth 10,000 yen to Shareholders holding 500 shares or more. ▽ Kaken Pharmaceutical <4521.T> set a maximum acquisition limit of 1.8 million shares (4.52% of the total issued shares excluding treasury stock) and a 9 billion yen share buyback limit, and as of May 30, 1.8 million shares (3.91% of the issued shares before cancellation) were canceled. ▽
Asahi Organic Chemicals has revised its operating profit downwards on March 25, from 12 billion yen to 10.5 billion yen.
Asahi Organic Chemicals announced a revision of its Financial Estimates for the fiscal year ending March 2025. Revenue has been revised down from 87 billion yen to 84 billion yen and operating profit from 12 billion yen to 10.5 billion yen. This is due to the postponement and review of semiconductor-related projects in the pipe system business, as well as a decrease in sales volume of base material products in the resin business, which indicates that the estimates will likely fall short of the previous announcement. 【Positive Evaluation】<1723> Nippon Dengi Revision | 【Negative Evaluation】<9885> Sharure Revision | <